ProfileGDS5822 / ILMN_1259606
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 46% 64% 59% 43% 66% 70% 65% 62% 66% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 120.346
GSM1276600PDAC Late Ablation Control 237.664
GSM1276601PDAC Late Ablation Control 331.859
GSM1276602PDAC Late Ablation 116.943
GSM1276603PDAC Late Ablation 242.666
GSM1276604PDAC Late Ablation 35870
GSM1303940PDAC Late Ablation_anti-CTLA4 135.465
GSM1303941PDAC Late Ablation_anti-CTLA4 239.862
GSM1303942PDAC Late Ablation_anti-CTLA4 352.866